Psilocybin Microdosing on Cognition, Mood and Quality of Life

Clinical trial NCT07449351 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07449351
Sponsor: Yale University
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Psychedelic Microdosing Effects on Mood, Cognition, Subjective Well-being and MRI

Start date: 2026-08-10
Primary completion: 2028-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.